Ibrutinib Plus Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Results from a Multicenter, Phase 2 StudyNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|Blood|2015Cited by 35
The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphomaNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|British Journal of Haematology|2020Cited by 28
Ibrutinib Combined with Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Arm 1 + Arm 2 Results from a Multicenter, Open-Label Phase 2 StudyNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|Blood|2016Cited by 9
The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasmRoberta S. Azevedo, N. Pemmaraju, Zohra Nooruddin et al.|Expert Opinion on Biological Therapy|2025Cited by 0
The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasmRoberta S. Azevedo, N. Pemmaraju, Zohra Nooruddin et al.|Figshare|2025Cited by 0